If you have been reading about heptapeptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-06-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It corresponds to the ACTH(4-7) fragment extended at the C-terminus by a Pro-Gly-Pro tripeptide, an addition intended to slow enzymatic breakdown. The molecular formula is C37H51N9O10S and the molecular mass is approximately 814 daltons. In the literature it is often described as an ACTH(4-10) analog, although that label reflects a naming convention as much as a precise structural relationship. The compound was developed in Russia and remains most closely associated with that research tradition.
Laboratory descriptions of the material are consistent across suppliers. It appears as a white to off-white lyophilized powder that dissolves readily in water and in polar organic solvents such as dimethyl sulfoxide. Aqueous solutions are clear and colorless at low concentrations. Because the peptide contains methionine, oxidation at the sulfur atom is a recognized degradation pathway, and handling notes usually call for protected, desiccated storage. Reported purity for research-grade lots is generally above 95 percent as measured by reversed-phase high-performance liquid chromatography.
The compound is registered in Russia as a pharmaceutical product, most commonly formulated as a nasal solution, and has been used in that setting since the 1990s. Outside that jurisdiction it is generally handled as a research chemical rather than an approved medicine. Regulatory status therefore differs sharply between countries, and material sold internationally may not correspond to the Russian pharmaceutical formulation. Documentation with commercial samples is typically limited to a certificate of analysis covering purity and identity, not clinical status or local legal classification.
Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.
Later generations of the molecule include an N-acetylated form and an amidated form, both marketed online alongside the parent peptide. These variants differ in terminal chemistry and stability, and they are frequently discussed in the same breath even though they have not been compared in controlled trials. Supply outside formal healthcare systems comes largely from laboratories that synthesize peptides to order. Purity and identity of these materials vary widely, and no single body oversees the international trade.
Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C37H51N9O10S | Contains one methionine sulfur atom |
| Molecular mass | Approximately 814 Da | Consistent with a seven-residue peptide |
| Appearance | White to off-white powder | Typical lyophilized form |
| Solubility | Freely soluble in water | Also soluble in dimethyl sulfoxide |
| Typical storage | -20 °C, desiccated | Limits methionine oxidation |
Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.
Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.
The parent fragment ACTH(4-10) carries the sequence Met-Glu-His-Phe-Arg-Trp-Gly. Semax replaces the arginine and tryptophan positions with a proline-glycine-proline tail, giving Met-Glu-His-Phe-Pro-Gly-Pro. That change removes residues associated with adrenal stimulation, so the peptide does not drive cortisol release the way full ACTH does. This distinction shapes how the compound is grouped in the literature, where it sits with neuropeptides and peptide neuromodulators rather than with corticosteroids.
== Production == Alliance Medical and Siemens Healthcare are the only producers in the United Kingdom. A dose of FDG in England costs about £130. In Northern Ireland, where there is a single supplier, doses cost up to £450. IBA Molecular North America and Zevacor Molecular, both of which are owned by Illinois Health and Science (IBAM having been purchased as of 1 August 2015), Siemens' PETNET Solutions (a subsidiary of Siemens Healthcare), and Cardinal Health are producers in the U.S.
On 15 June, US vice president JD Vance announced that the memorandum was digitally signed by both countries the previous day. On 17 June, Trump and Iranian president Masoud Pezeshkian signed the Islamabad Memorandum to end the war, with Trump signing it during dinner with French president Emmanuel Macron at the Palace of Versailles after the G7 summit. On 18 June, Pakistan stated that the signing of the memorandum implies Tehran will reopen the Strait of Hormuz "instantly" and the American blockade will end "immediately." CENTCOM announced that it had removed the naval blockade. On 19 June, Trump announced a renewed ceasefire between Israel and Hezbollah in the 2026 Lebanon war, facilitated by the US, Qatar, and Iran. However, on 20 June, Hezbollah announced an attack on Israeli forces trying to capture Ali al-Taher in Nabatieh, while Israel continued to strike southern Lebanon.
Patent leather is leather that has been given a high-gloss finish by the addition of a coating. Dating to the late 1700s, it became widely popular after inventor Seth Boyden developed the first mass-production process, using a linseed-oil-based lacquer, in 1818. Modern versions are usually a form of bicast leather. Suede is made from the underside of a split to create a soft, napped finish. It is often made from younger or smaller animals, as the skins of adults often result in a coarse, shaggy nap. Bonded leather, also called reconstituted leather, is a material that uses leather scraps that are shredded and bonded together with polyurethane or latex onto a fiber mesh. The amount of leather fibers in the mix varies from 10% to 90%, affecting the properties of the product. The term "genuine leather" does not describe a specific grade. The term often indicates split leather that has been extensively processed, and some sources describe it as synonymous with bicast leather, or made from multiple splits glued together and coated. In some countries, when it is the description on a product label the term means nothing more than "contains leather"; depending on jurisdiction, regulations limit the term's use in product labelling.
The article cites the attempts to replicate Hamer's work, some supportive and some not. It concludes, "Although it is encouraging that the largest study replicated some findings from smaller studies, the case is not closed. Still larger studies are needed to provide the degree of certainty now expected in molecular genetics, and in any case, the mapping case is not closed in molecular genetics until one has identified the genes that affect a trait." Hamer and colleagues also investigated the genetic roots of anxiety and found that a promoter region polymorphism in the gene for the serotonin transporter, which is the target of antidepressant drugs such as Prozac, is associated with mood and personality. This finding has been extensively replicated and extended and its activity has been confirmed by direct brain imaging studies. In 2004, Hamer used data from ongoing behavioral genetics studies in his lab to explore the possibility of genetic influences on spirituality. In The God Gene: How Faith is Hardwired into our Genes, he proposed that a quantitative measure of self-transcendence is partially heritable and may be correlated to a specific gene, VMAT2, involved in monamine metabolism. Hamer's speculations on the possible role of genetics in religious experience were featured in a cover story in Time magazine.
Sources: en.wikipedia.org
Glutathione peroxidase 1, also known as GPx1, is an enzyme that in humans is encoded by the GPX1 gene on chromosome 3. This gene encodes a member of the glutathione peroxidase family. Glutathione peroxidase functions in the detoxification of hydrogen peroxide, and is one of the most important antioxidant enzymes in humans.
== Application == In molecular biology, 2A peptides are used to express two separate proteins from a single open-reading frame. 2A peptides can be used when direct protein fusion does not work or is undesirable.
Some of the Democratic National Committee (DNC) emails leaked to the public in June and July 2016 showed that the committee leadership had favored Clinton over him and had worked to help Clinton win the nomination. On July 12, 2016, Sanders formally endorsed Clinton in her unsuccessful general election campaign against Republican Donald Trump, while urging his supporters to continue the "political revolution" his campaign had begun. Following his endorsement, Sanders spent weeks campaigning for Clinton, holding 39 rallies in 13 states during the final three months before the 2016 election.
=== Polymer shell protein core === A polymer shell is formed by conjugation of multiple molecules of polymers onto the protein core. The polymer shell can either protect the protein core from unwanted degradation or create desired interactive sites for guest molecules. The first generation of polymer shell protein core structures mainly used of Polyethylene glycol (PEG) chains to increase the hydrodynamic radius and reduce immune response to proteins. However, the PEG shell can reduce protein activity in the inner core. More advanced designs use biodegradable linkers to achieve programmed release of the protein core in specific tissues. Several therapeutic designs with biodegradable PEG shells are already being developed in vivo. Direct conjugation of polymers ("grafting to" strategy) can efficiently construct a polymer shell with diverse polymer types, however, it has low polymer density, especially with large polymers. In contrast, "grafting from" strategy allows the formation of a dense and uniform polymer shell. The protein core can also function as a carrier for other therapeutic molecules, such as plasmid DNA. Dendrite polymer shells have a high volume to molecular weight ratio compared with traditional polymer shells. Using branched carbohydrates can give unique biological properties while maintaining molecular definition.
== Epidemiology == Female androgenic alopecia has become a growing problem that, according to the American Academy of Dermatology, affects around 30 million women in the United States. Although hair loss in females normally occurs after the age of 50 or even later when it does not follow events like pregnancy, chronic illness, crash diets, and stress among others, it is now occurring at earlier ages with reported cases in women as young as 15 or 16. 30–50% of men have male androgenic alopecia by the age of 50; hereditarily, there is an 80% predisposition. The link between androgenetic alopecia and metabolic syndrome is strongest in non-obese men.
Sources: en.wikipedia.org
It is registered as a pharmaceutical product in Russia, where it is typically supplied as a nasal solution. In most other countries it is not an approved drug and is traded as a research chemical instead. Approval status depends entirely on the jurisdiction involved.
Most published work uses intranasal administration, matching the route of the registered Russian formulation. Some animal experiments use intravenous or intraperitoneal injection. The route matters because the intact peptide is cleared rapidly from blood, so exposure differs between methods.
A purity value describes the share of the powder accounted for by the target peptide, usually by high-performance liquid chromatography. It does not confirm that the sequence is correct, which requires mass spectrometry or amino acid analysis. Purity and identity are separate checks.
It originated at the Institute of Molecular Genetics in Moscow during the 1980s. The work was carried out by a Russian research group that specialized in peptide neuropharmacology.